US equities
|
SPCX
$160.29
▲+8.46%
MU
$917.61
▲+2.40%
NVDA
$221.47
▲+2.31%
TSLA
$387.24
▲+3.62%
META
$706.94
▲+1.83%
SNDK
$1,390.49
▲+1.84%
GOOGL
$334.52
▼-1.69%
AAPL
$344.52
▲+1.48%
SPCX
$160.29
▲+8.46%
MU
$917.61
▲+2.40%
NVDA
$221.47
▲+2.31%
TSLA
$387.24
▲+3.62%
META
$706.94
▲+1.83%
SNDK
$1,390.49
▲+1.84%
GOOGL
$334.52
▼-1.69%
AAPL
$344.52
▲+1.48%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Tzield
Recent news which mentions Tzield
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
December 02, 2022
Tickers
AMGN
CHRS
CYTK
IBB
Tags
Penny Stocks
Tzield
SPPI
From
Benzinga